Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-11
2008-03-11
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07342033
ABSTRACT:
Methods and compositions for the treatment of multiple sclerosis comprising riluzole (6-(trifluoromethoxy)-benzothiazolamine) are disclosed herein.
REFERENCES:
patent: 4826860 (1989-05-01), Johnson et al.
patent: 5236940 (1993-08-01), Audiau et al.
patent: 5668117 (1997-09-01), Shapiro
patent: 5780489 (1998-07-01), Brooks
patent: 6245791 (2001-06-01), Bohme et al.
patent: 6387936 (2002-05-01), Blanchard Bregeon et al.
patent: 6872739 (2005-03-01), Polman
patent: 2003/0077641 (2003-04-01), Laskowitz et al.
patent: 0 558 861 (1993-09-01), None
patent: WO 93/17683 (1993-09-01), None
patent: 98/41882 (1998-09-01), None
patent: WO 98/41882 (1998-09-01), None
patent: WO 99/51097 (1999-01-01), None
patent: WO 99/47692 (1999-09-01), None
patent: WO 00/54773 (2000-09-01), None
patent: WO 01/95907 (2001-12-01), None
Harvey, A.L., Med. Res. Rev. (13, No. 1, 81-104, 1993) (abstract).
Harvard Women's Health Watch Newsletter (Feb. 1, 1998), vol. 5.
The Merck Index (1999), 17thedition, pp. 1474-1476.
Kalkers “A pilot study of riluzole in primary progressive multiple sclerosis; effect on spinal cord atrophy on MRI”9thMeeting of the European Neurological SocietyPoster P419, Abstract (1999).
McCready “Rilutek might be tried for MS”MS PathfinderAbstract (1998).
Schluep et al.Medecine et Hygiene55/2145:33-35 Abstract (1997).
Stankoff “Neuroprotection and Central Nervous System myelination: New prospects for multiple sclerosis?”Neurology52(6):A402 Abstract (1999).
Kalkers et al., “The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study”Multiple Sclerosis8:532-533 (2002).
Harvey, “Neuropharmacology of Potassium Ion Channels”Medicinal Research Reviews13(1):81-104 (Jan. 1993).
Harvard Women's Health Watch, vol. V, No. 6 (Feb. 1998).
Fish & Richardson P.C.
Spivack Phyllis G.
Vereniging Voor Christelijk Wetenschappelijk Onderwijs
LandOfFree
Use of riluzole for the treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of riluzole for the treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of riluzole for the treatment of multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2811380